Skip to main content
Haleon PLC logo

Haleon PLC — Investor Relations & Filings

Ticker · HLN ISIN · GB00BMX86B70 LEI · 549300PSB3WWEODCUP19 IL Manufacturing
Filings indexed 905 across all filing types
Latest filing 2026-05-07 Regulatory Filings
Country GB United Kingdom
Listing IL HLN

About Haleon PLC

https://www.haleon.com/

Haleon PLC is a global consumer healthcare company focused on improving everyday health. The company develops and markets a portfolio of category-leading brands built on scientific innovation and trusted by consumers and healthcare professionals. Its product offerings span several key categories, including Oral Health, Pain Relief, Respiratory Health, and Vitamins, Minerals, and Supplements. Notable brands within its portfolio include Sensodyne, Advil, Voltaren, and Centrum. Haleon's mission is to deliver better everyday health with humanity, making it more achievable, inclusive, and sustainable.

Recent filings

Filing Released Lang Actions
6-K - Haleon plc (0001900304) (Filer)
Regulatory Filings
2026-05-07 English
EMTN programme publication of listing particulars
Regulatory Filings Classification · 95% confidence The document is an announcement from Haleon plc dated 7 May 2026 regarding the publication of listing particulars for their Euro Medium Term Note (EMTN) Programme. It states that the listing particulars have been published and are available for download on the company's website. The document is relatively short (3720 characters) and primarily serves to inform about the availability of the listing particulars rather than containing the listing particulars themselves or detailed financial data. There is no detailed financial report, audit, or management discussion included. This fits the pattern of a Regulatory Filing (RNS) as it is a general regulatory announcement about the publication of a document rather than the document itself or a detailed financial report.
2026-05-07 English
6-K - Haleon plc (0001900304) (Filer)
Regulatory Filings
2026-05-05 English
Transactions in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an announcement from Haleon plc detailing the purchase of its own shares under a share buyback program, including specific dates, volumes, and prices of shares bought. It explicitly states the number of shares held as treasury shares and the resulting voting rights. The content focuses on transactions in the company's own shares and does not contain financial statements or broader financial performance data. This matches the definition of a 'Transaction in Own Shares' filing, which reports share repurchase activities. The document length is 5877 characters, sufficient to provide detailed transaction data, not just a brief announcement or link to a report. Therefore, the correct classification is POS (Transaction in Own Shares).
2026-05-05 English
6-K - Haleon plc (0001900304) (Filer)
Regulatory Filings
2026-05-01 English
Total Voting Rights and Capital
Regulatory Filings Classification · 95% confidence The document is a regulatory news service (RNS) announcement from Haleon plc dated 01 May 2026. It provides the total number of shares issued, treasury shares, and the number of ordinary shares with voting rights as of 30 April 2026. The content focuses on voting rights and share capital information, intended for shareholders and those with notification obligations under FCA rules. The document is short (2844 characters) and does not contain financial statements, management discussion, or detailed report data. It is an announcement of share capital and voting rights information rather than a full report or detailed filing. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2026-05-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.